10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001035267-21-000119`
Period End Date	20210630
Filing Date	20210721
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	isrg-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 80 Cash Flow Statement 68

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.62B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.62B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.82B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$3.49B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$699.90M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$645.50M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Inventory	`InventoryNet`	$601.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$569.70M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.70M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	118.70M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$307.80M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$267.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.63B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	118.70M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.70M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.02B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.65B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.58B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.76B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$3.30B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$394.40M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$367.70M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$503.60M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$594.90M	USD	Point-in-time
Goodwill	`Goodwill`	$344.30M	USD	Point-in-time
Goodwill	`Goodwill`	$336.70M	USD	Point-in-time
Total assets	`Assets`	$11.17B	USD	Point-in-time
Total assets	`Assets`	$12.30B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$81.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$117.90M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$235.00M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$254.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$350.30M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$360.00M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$298.30M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$272.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.00B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$965.20M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$412.90M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$444.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.42B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.41B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2021, and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2021, and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 118.7 shares and 117.7 shares issued and outstanding as of June 30, 2021, and December 31, 2020, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 118.7 shares and 117.7 shares issued and outstanding as of June 30, 2021, and December 31, 2020, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.80B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.45B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.02B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.26B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$10.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$24.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$12.40M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$8.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$11.40M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$22.30M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$9.73B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$10.84B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$42.00M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$27.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.53B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.76B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.88B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.77B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$12.30B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.17B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.76B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.95B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$852.10M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.46B	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$440.30M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$829.80M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$710.50M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$349.20M	USD	1 Quarter
Gross profit	`GrossProfit`	$502.90M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.02B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.93B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.24B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$676.20M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$350.20M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$279.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$587.20M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$143.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$322.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$162.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$290.30M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$422.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$512.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$877.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$998.30M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$363.60M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$511.20M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$80.60M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$928.00M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$15.00M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$47.00M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$26.60M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$51.70M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$107.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$526.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$415.30M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$975.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$37.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$28.90M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$3.20M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$16.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$523.00M	USD	1 Quarter
Net income	`ProfitLoss`	$958.20M	USD	2 Qtrs
Net income	`ProfitLoss`	$70.20M	USD	1 Quarter
Net income	`ProfitLoss`	$386.40M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.70M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.90M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.20M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$381.50M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$68.00M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$943.50M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$517.20M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.27	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.36	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$7.98	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.58	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.19	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.77	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.25	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.57	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.80M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	118.60M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	118.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	121.50M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.70M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	121.60M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.70M	shares	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$521.40M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$943.30M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$396.40M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$83.50M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$5.30M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$14.40M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$2.10M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$81.40M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$391.40M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$928.90M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$516.10M	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$523.00M	USD	1 Quarter
Net income	`ProfitLoss`	$958.20M	USD	2 Qtrs
Net income	`ProfitLoss`	$70.20M	USD	1 Quarter
Net income	`ProfitLoss`	$386.40M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$102.50M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$132.80M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$14.50M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$7.50M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.70M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$12.40M	USD	1 Quarter
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.40M	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$4.30M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.50M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-24.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$211.30M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$186.50M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$10.00M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$8.20M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$59.60M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-136.90M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$120.10M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$92.40M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$177.00M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$95.50M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.60M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$38.20M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$19.00M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-83.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$10.60M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$4.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-14.50M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-17.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.02B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$582.70M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.43B	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$3.51B	USD	2 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$72.10M	USD	2 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$800.70M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.60B	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.30B	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$215.20M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$134.30M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$37.70M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.70M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$419.60M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-981.70M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$154.00M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$153.70M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.90M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$155.10M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$100.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-9.70M	USD	2 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-30.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-131.10M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-43.90M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.60M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.60M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$869.60M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.90M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.64B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.64B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.